Keduo Qian

Title: Keduo Qian: Innovator in Antitumor Agents

Introduction

Keduo Qian is a notable inventor based in Clarksburg, MD (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents. His innovative work focuses on novel compounds that have the potential to treat various types of cancer.

Latest Patents

Keduo Qian holds 1 patent related to his research. The patent involves novel 20-sulfonylamidine derivatives of camptothecin, a compound known for its antitumor properties. This invention outlines a method for synthesizing these derivatives and their application as an antitumor agent, specifically targeting nasopharyngeal, lung, breast, or prostate cancer.

Career Highlights

Throughout his career, Keduo Qian has worked with esteemed institutions such as China Medical University Hospital and the University of North Carolina at Chapel Hill. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Keduo Qian has collaborated with notable colleagues, including Kuo-Hsiung Lee and Xiaoming Yang. These partnerships have contributed to the advancement of his research and the development of innovative therapeutic solutions.

Conclusion

Keduo Qian's work in the field of antitumor agents exemplifies the impact of innovative research on cancer treatment. His contributions continue to pave the way for new therapeutic options in oncology.